Leading innovative Israeli life science companies use to effectively manage their global clinical trial data in Europe and the United States.

Read the case studies of innovative life science companies that accelerated their time to market with

OCON Medical

OCON develops and markets innovative and cost effective quality intrauterine technology that improves the health and quality of life of women all over the world.

OCON Medical has its roots in the summer of 2008 when Dr. Ilan Baram, MD, had a serendipitous idea that ball-shaped IUDs would minimize risks and endometrial irritation.

OCON used as a highly cost-effective solution to manage and monitor their clinical trials operations in Central Europe and Israel utilizing to help accelerate time to study completion by pinpointing data quality issues and ensuring delivery of high quality data to the biostatistics team.

Ariel Weinstein, CEO OCON Medical:
“Our experience shows that anyone looking for reliable cloud EDC with excellent service and superb cost-benefit ratio should have on the top of their list.”

Exalenz Bioscience

Exalenz Bioscience Ltd. develops and commercializes advanced medtech systems that extract vital information for diagnostics from subtle changes in the patient’s exhaled breath based on its BreathID technology platform. These products improve the quality of patient care, enhance clinic and medical center efficiencies and fuel revenue generation. Exalenz proprietary core technology enables medical specialists to identify and manage specific digestive and liver conditions with unprecedented ease, patient comfort, and clinical precision.

Exalenz used to as a highly cost-effective solution to manage and monitor their portfolio of global multi-center medical device clinical trials at a large number of medical centers in Western Europe, the United States and Israel.


ElMindA was founded in 2006, with the vision of revolutionizing the management of brain disorders and injuries, by transforming state of the art neuroscience into bedside clinical practice, opening a new window into our brain’s functionality, and enabling well-informed clinical decision making. served Elminda as a clinical data collection and monitoring platform for their global portfolio of clinical research. With a challenging set of regulatory and medical requirements for data collection and clinical quality monitoring in a rapidly growing portfolio of studies. helped a small clinical operations team be very effective, reduce costs and shorten time to report with a system that runs entirely in the cloud.


OrthoSpace develops and commercializes simple-to-implant, biodegradable balloon systems for the orthopaedic market. The company aims to create effective solutions for orthopaedics that reduce pain and increase patients’ range of motion while preserving patient bone and joint structures.

The company’s first product has the CE mark and is currently marketed in Europe. InSpace™ is indicated for patients who suffer from rotator cuff injury, reducing shoulder pain and improving range of motion.

“FlaskData is a fascinating and novel tool for reinforcing patient adherence.

We look forward to seeing continue to develop and disseminate the technology in the EU.

The ability of a smart mobile agent to increase patient’s compliance to a clinical protocol can have a significant impact on obtaining statistically-meaningful results in clinical trials and immense importance for medical practice.

We are currently working with in post-marketing studies, monitoring for patient safety and compliance in the UK and the EU.”

Elana Markovitz
Orthospace – a Stryker Medical company
VP Clinical and Regulatory Affairs Caesaria, Israel

Vibrant Ltd.

Vibrant Ltd is a developer and producer of a chemical-free vibrating capsule for treatment of constipation. Vibrant developed a medtech, treatment and patient monitoring platform for various constipated patients. This innovative platform relies on known physiological parameters of large intestine peristaltic movement.

The first product based on Vibrant’s technology is a proprietary, biocompatible, chemical-free capsule providing effective aid for chronic constipation patients. Vibrant has successfully completed the Phase II clinical trial with positive signal of efficacy. The company completed recruitment of the Phase III, sham double-blind study with 150 patients in USA & Israel.

From Camille Morliere – VP Clinical, Vibrant Gastro: “It was a pleasure to work with The flexibility of their platform, combines EDC, electronic patient report outcomes with real-time protocol monitoring. The delivery of an integrated digital clinical trial management system developed for our unique usage is especially appreciated. The system is intuitive and easy to use, while providing a wide range of services.

During the development phase, the team made itself extremely available and managed to resolve all issues in a timely manner. They rose up to the challenge always with a positive attitude.

We find the team to be reliable and we are looking forward to continuing our partnership with”